Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables

Cancer Causes and Control

Volumn 26, Issue 1, 2015, Pages 45-56

  Wang, Chun ^a,b   Civan, Jesse ^c   Lai, Yinzhi ^a   Cristofanilli, Massimo ^a   Hyslop, Terry ^d   Palazzo, Juan P ^c   Myers, Ronald E ^a   Li, Bingshan ^e   Ye, Zhong ^a   Zhang, Kejin ^a   Xing, Jinliang ^f   Yang, Hushan ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NANTONG UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Hematologic variables; Hemoglobin; Racial disparity; Survival

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DRINKING; ERYTHROCYTE; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; SMOKING; AGED; BREAST TUMOR; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; HEALTH DISPARITY; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; UNITED STATES;

AGED; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84938080408     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0481-4     Document Type: Article

References (54)

1. American Cancer Society (2013) Cancer Facts & Figures 2013. http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
2. DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62
3. Howlader N, Noone AM, Krapcho M et al (2013) SEER cancer statistics review, 1975–2010: SEER incidence, US mortality, SEER relative Survival. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2010/. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013
4. Maskarinec G, Sen C, Koga K, Conroy SM (2011) Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) 7:677–687
5. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomark Prev 18:121–131
6. Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183
7. Pulte D, Redaniel MT, Brenner H, Jeffreys M (2012) Changes in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing? Ann Oncol 23:2428–2434
8. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349
9. Deshpande AD, Jeffe DB, Gnerlich J, Iqbal AZ, Thummalakunta A, Margenthaler JA (2009) Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res 153:105–113
10. Brawley OW (2013) Health disparities in breast cancer. Obstet Gynecol Clin N Am 40:513–523
11. Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) 18:883–893
12. Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15
13. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101:984–992
14. Silber JH, Rosenbaum PR, Clark AS et al (2013) Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310:389–397
15. Cheng CK, Chan J, Cembrowski GS, van Assendelft OW (2004) Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 10:42–53
16. Meyers LD, Habicht JP, Johnson CL (1979) Components of the difference in hemoglobin concentrations in blood between black and white women in the United States. Am J Epidemiol 109:539–549
17. Pan WH, Habicht JP (1991) The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women. Am J Epidemiol 134:1410–1416
18. Beutler E, West C (2005) Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106:740–745
19. Perry GS, Byers T, Yip R, Margen S (1992) Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr 122:1417–1424
20. Mohamed MA, Ahmad T, Macri C, Aly H (2012) Racial disparities in maternal hemoglobin concentrations and pregnancy outcomes. J Perinat Med 40:141–149
21. Patel KV, Longo DL, Ershler WB et al (2009) Hemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III follow-up. Br J Haematol 145:514–523
22. Wan S, Lai Y, Myers RE et al (2013) Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies—results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer 13:340
23. Metzger ML, Castellino SM, Hudson MM et al (2008) Effect of race on the outcome of pediatric patients with Hodgkin’s lymphoma. J Clin Oncol 26:1282–1288
24. Haddy TB, Castro OL, Rana SR (1987) Hemoglobin and MCV values in 4,074 healthy black children and adolescents. J Natl Med Assoc 79:75–78
25. Yang H, Lippman SM, Huang M et al (2008) Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer 44:1603–1611
26. Greene FL, American Joint Committee on C, American Cancer S (2002) AJCC cancer staging handbook: from the AJCC cancer staging manual. Springer, New York
27. Rosenbaum PR, Ross RN, Silber JH (2007) Minimum distance matched sampling with fine balance in an observational study of treatment for ovarian cancer. J Am Stat Assoc 102:75–83
28. Heller R, Rosenbaum PR, Small D (2010) Using the cross-match test to appraise covariate balance in matched pairs. Am Stat 64:299–309
29. Early Breast Cancer Trialists’ Collaborative G, Peto R, Davies C et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379:432–444
30. Mandelblatt JS, Sheppard VB, Neugut AI (2013) Black–white differences in breast cancer outcomes among older Medicare beneficiaries: does systemic treatment matter? JAMA 310:376–377
31. Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171–180
32. Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23:6639–6646
33. Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252
34. Early Breast Cancer Trialists’ Collaborative G, Davies C, Godwin J et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784
35. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR (2006) Impact of anemia on hospitalization and mortality in older adults. Blood 107:3841–3846
36. Dong X, Mendes de Leon C, Artz A, Tang Y, Shah R, Evans D (2008) A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 63:873–878
37. Penninx BW, Pahor M, Woodman RC, Guralnik JM (2006) Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 61:474–479
38. Zakai NA, Katz R, Hirsch C et al (2005) A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 165:2214–2220
39. Mayr NA, Wang JZ, Zhang D et al (2009) Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer. Int J Radiat Oncol Biol Phys 74:1513–1521
40. Vaupel P, Kelleher DK, Hoeckel M (2001) Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28:29–35
41. Kim JY, Shin S, Han K et al (2014) Relationship between socioeconomic status and anemia prevalence in adolescent girls based on the fourth and fifth Korea National Health and Nutrition Examination Surveys. Eur J Clin Nutr 68:253–258
42. Animasahun BA, Temiye EO, Ogunkunle OO, Izuora AN, Njokanma OF (2011) The influence of socioeconomic status on the hemoglobin level and anthropometry of sickle cell anemia patients in steady state at the Lagos University Teaching Hospital. Niger J Clin Pract 14:422–427
43. Leite MS, Cardoso AM, Coimbra CE Jr et al (2013) Prevalence of anemia and associated factors among indigenous children in Brazil: results from the First National Survey of Indigenous People’s Health and Nutrition. Nutr J 12:69
44. Chu QD, Smith MH, Williams M et al (2009) Race/ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital. Cancer Epidemiol Biomark Prev 18:2157–2161
45. Li J, Glessner JT, Zhang H et al (2013) GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum Mol Genet 22:1457–1464
46. Bauer DE, Kamran SC, Lessard S et al (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342:253–257
47. Shameer K, Denny JC, Ding K et al (2014) A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum Genet 133:95–109
48. Crosslin DR, McDavid A, Weston N et al (2013) Genetic variation associated with circulating monocyte count in the eMERGE network. Hum Mol Genet 22:2119–2127
49. Cresanta JL, Croft JB, Webber LS, Nicklas TA, Berenson GS (1987) Racial difference in hemoglobin concentration of young adults. Prev Med 16:659–669
50. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104:2263–2268
51. Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig 113:1271–1276
52. Kosoy R, Nassir R, Tian C et al (2009) Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 30:69–78
53. Xu H, Cheng C, Devidas M et al (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30:751–757
54. Bovell LC, Shanmugam C, Putcha BD et al (2013) The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res 19:3955–3965